Global Oral Codeine Tablet Market Growth 2024-2030

Publication ID:

LPI06242438

Publication Date:

June 13, 2024

Pages:

142

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Oral Codeine Tablet market size was valued at US$ 666.7 million in 2023. With growing demand in downstream market, the Oral Codeine Tablet is forecast to a readjusted size of US$ 956.4 million by 2030 with a CAGR of 5.3% during review period.
The research report highlights the growth potential of the global Oral Codeine Tablet market. Oral Codeine Tablet are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Oral Codeine Tablet. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Oral Codeine Tablet market.
Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.
The Codeine Narcotic market is driven by the demand for effective pain management and the widespread use of codeine as an analgesic and antitussive medication. Codeine, a narcotic drug derived from opium, is prescribed to alleviate moderate to severe pain and suppress coughing. The prevalence of conditions causing pain, such as post-surgery recovery and chronic illnesses, contributes to market growth as healthcare professionals seek safe and accessible pain relief options. Moreover, codeine's relatively lower potential for abuse compared to other narcotics aligns with its continued medical use. However, the market also faces challenges, including the potential for misuse and addiction due to codeine's opioid properties, leading to regulatory controls and prescription limitations in various regions. Additionally, addressing patient education about codeine's potential risks and benefits, and ensuring proper dosing and monitoring can pose obstacles for healthcare providers. To succeed, pharmaceutical companies must focus on responsible prescribing practices, patient education, and addressing the challenges to ensure the appropriate use of codeine while providing effective pain management solutions that prioritize patient safety.
Key Features:
The report on Oral Codeine Tablet market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Oral Codeine Tablet market. It may include historical data, market segmentation by Type (e.g., Single-ingredient Codeine, Multi-ingredient Medications), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Oral Codeine Tablet market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Oral Codeine Tablet market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Oral Codeine Tablet industry. This include advancements in Oral Codeine Tablet technology, Oral Codeine Tablet new entrants, Oral Codeine Tablet new investment, and other innovations that are shaping the future of Oral Codeine Tablet.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Oral Codeine Tablet market. It includes factors influencing customer ' purchasing decisions, preferences for Oral Codeine Tablet product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Oral Codeine Tablet market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Oral Codeine Tablet market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Oral Codeine Tablet market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Oral Codeine Tablet industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Oral Codeine Tablet market.
Market Segmentation:
Oral Codeine Tablet market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Single-ingredient Codeine
Multi-ingredient Medications
Segmentation by application
Narcotic Analgesic
Antitussive
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva
Key Questions Addressed in this Report
What is the 10-year outlook for the global Oral Codeine Tablet market?
What factors are driving Oral Codeine Tablet market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oral Codeine Tablet market opportunities vary by end market size?
How does Oral Codeine Tablet break out type, application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oral Codeine Tablet Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Oral Codeine Tablet by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Oral Codeine Tablet by Country/Region, 2019, 2023 & 2030
2.2 Oral Codeine Tablet Segment by Type
2.2.1 Single-ingredient Codeine
2.2.2 Multi-ingredient Medications
2.3 Oral Codeine Tablet Sales by Type
2.3.1 Global Oral Codeine Tablet Sales Market Share by Type (2019-2024)
2.3.2 Global Oral Codeine Tablet Revenue and Market Share by Type (2019-2024)
2.3.3 Global Oral Codeine Tablet Sale Price by Type (2019-2024)
2.4 Oral Codeine Tablet Segment by Application
2.4.1 Narcotic Analgesic
2.4.2 Antitussive
2.4.3 Others
2.5 Oral Codeine Tablet Sales by Application
2.5.1 Global Oral Codeine Tablet Sale Market Share by Application (2019-2024)
2.5.2 Global Oral Codeine Tablet Revenue and Market Share by Application (2019-2024)
2.5.3 Global Oral Codeine Tablet Sale Price by Application (2019-2024)
3 Global Oral Codeine Tablet by Company
3.1 Global Oral Codeine Tablet Breakdown Data by Company
3.1.1 Global Oral Codeine Tablet Annual Sales by Company (2019-2024)
3.1.2 Global Oral Codeine Tablet Sales Market Share by Company (2019-2024)
3.2 Global Oral Codeine Tablet Annual Revenue by Company (2019-2024)
3.2.1 Global Oral Codeine Tablet Revenue by Company (2019-2024)
3.2.2 Global Oral Codeine Tablet Revenue Market Share by Company (2019-2024)
3.3 Global Oral Codeine Tablet Sale Price by Company
3.4 Key Manufacturers Oral Codeine Tablet Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Codeine Tablet Product Location Distribution
3.4.2 Players Oral Codeine Tablet Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Oral Codeine Tablet by Geographic Region
4.1 World Historic Oral Codeine Tablet Market Size by Geographic Region (2019-2024)
4.1.1 Global Oral Codeine Tablet Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Oral Codeine Tablet Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Oral Codeine Tablet Market Size by Country/Region (2019-2024)
4.2.1 Global Oral Codeine Tablet Annual Sales by Country/Region (2019-2024)
4.2.2 Global Oral Codeine Tablet Annual Revenue by Country/Region (2019-2024)
4.3 Americas Oral Codeine Tablet Sales Growth
4.4 APAC Oral Codeine Tablet Sales Growth
4.5 Europe Oral Codeine Tablet Sales Growth
4.6 Middle East & Africa Oral Codeine Tablet Sales Growth
5 Americas
5.1 Americas Oral Codeine Tablet Sales by Country
5.1.1 Americas Oral Codeine Tablet Sales by Country (2019-2024)
5.1.2 Americas Oral Codeine Tablet Revenue by Country (2019-2024)
5.2 Americas Oral Codeine Tablet Sales by Type
5.3 Americas Oral Codeine Tablet Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Codeine Tablet Sales by Region
6.1.1 APAC Oral Codeine Tablet Sales by Region (2019-2024)
6.1.2 APAC Oral Codeine Tablet Revenue by Region (2019-2024)
6.2 APAC Oral Codeine Tablet Sales by Type
6.3 APAC Oral Codeine Tablet Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Oral Codeine Tablet by Country
7.1.1 Europe Oral Codeine Tablet Sales by Country (2019-2024)
7.1.2 Europe Oral Codeine Tablet Revenue by Country (2019-2024)
7.2 Europe Oral Codeine Tablet Sales by Type
7.3 Europe Oral Codeine Tablet Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oral Codeine Tablet by Country
8.1.1 Middle East & Africa Oral Codeine Tablet Sales by Country (2019-2024)
8.1.2 Middle East & Africa Oral Codeine Tablet Revenue by Country (2019-2024)
8.2 Middle East & Africa Oral Codeine Tablet Sales by Type
8.3 Middle East & Africa Oral Codeine Tablet Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Codeine Tablet
10.3 Manufacturing Process Analysis of Oral Codeine Tablet
10.4 Industry Chain Structure of Oral Codeine Tablet
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Codeine Tablet Distributors
11.3 Oral Codeine Tablet Customer
12 World Forecast Review for Oral Codeine Tablet by Geographic Region
12.1 Global Oral Codeine Tablet Market Size Forecast by Region
12.1.1 Global Oral Codeine Tablet Forecast by Region (2025-2030)
12.1.2 Global Oral Codeine Tablet Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oral Codeine Tablet Forecast by Type
12.7 Global Oral Codeine Tablet Forecast by Application
13 Key Players Analysis
13.1 Taiji
13.1.1 Taiji Company Information
13.1.2 Taiji Oral Codeine Tablet Product Portfolios and Specifications
13.1.3 Taiji Oral Codeine Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Taiji Main Business Overview
13.1.5 Taiji Latest Developments
13.2 Mallinckrodt
13.2.1 Mallinckrodt Company Information
13.2.2 Mallinckrodt Oral Codeine Tablet Product Portfolios and Specifications
13.2.3 Mallinckrodt Oral Codeine Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Mallinckrodt Main Business Overview
13.2.5 Mallinckrodt Latest Developments
13.3 TEVA
13.3.1 TEVA Company Information
13.3.2 TEVA Oral Codeine Tablet Product Portfolios and Specifications
13.3.3 TEVA Oral Codeine Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 TEVA Main Business Overview
13.3.5 TEVA Latest Developments
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Information
13.4.2 Johnson & Johnson Oral Codeine Tablet Product Portfolios and Specifications
13.4.3 Johnson & Johnson Oral Codeine Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Johnson & Johnson Main Business Overview
13.4.5 Johnson & Johnson Latest Developments
13.5 Medreich
13.5.1 Medreich Company Information
13.5.2 Medreich Oral Codeine Tablet Product Portfolios and Specifications
13.5.3 Medreich Oral Codeine Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Medreich Main Business Overview
13.5.5 Medreich Latest Developments
13.6 Sanofi Aventis
13.6.1 Sanofi Aventis Company Information
13.6.2 Sanofi Aventis Oral Codeine Tablet Product Portfolios and Specifications
13.6.3 Sanofi Aventis Oral Codeine Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Sanofi Aventis Main Business Overview
13.6.5 Sanofi Aventis Latest Developments
13.7 Cipla
13.7.1 Cipla Company Information
13.7.2 Cipla Oral Codeine Tablet Product Portfolios and Specifications
13.7.3 Cipla Oral Codeine Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Cipla Main Business Overview
13.7.5 Cipla Latest Developments
13.8 Hikma
13.8.1 Hikma Company Information
13.8.2 Hikma Oral Codeine Tablet Product Portfolios and Specifications
13.8.3 Hikma Oral Codeine Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Hikma Main Business Overview
13.8.5 Hikma Latest Developments
13.9 Pharmaceutical Associates
13.9.1 Pharmaceutical Associates Company Information
13.9.2 Pharmaceutical Associates Oral Codeine Tablet Product Portfolios and Specifications
13.9.3 Pharmaceutical Associates Oral Codeine Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Pharmaceutical Associates Main Business Overview
13.9.5 Pharmaceutical Associates Latest Developments
13.10 Novartis
13.10.1 Novartis Company Information
13.10.2 Novartis Oral Codeine Tablet Product Portfolios and Specifications
13.10.3 Novartis Oral Codeine Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Novartis Main Business Overview
13.10.5 Novartis Latest Developments
13.11 Apotex
13.11.1 Apotex Company Information
13.11.2 Apotex Oral Codeine Tablet Product Portfolios and Specifications
13.11.3 Apotex Oral Codeine Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Apotex Main Business Overview
13.11.5 Apotex Latest Developments
13.12 Mylan
13.12.1 Mylan Company Information
13.12.2 Mylan Oral Codeine Tablet Product Portfolios and Specifications
13.12.3 Mylan Oral Codeine Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Mylan Main Business Overview
13.12.5 Mylan Latest Developments
13.13 Aristo Pharma GmbH
13.13.1 Aristo Pharma GmbH Company Information
13.13.2 Aristo Pharma GmbH Oral Codeine Tablet Product Portfolios and Specifications
13.13.3 Aristo Pharma GmbH Oral Codeine Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Aristo Pharma GmbH Main Business Overview
13.13.5 Aristo Pharma GmbH Latest Developments
13.14 Lannett Company
13.14.1 Lannett Company Company Information
13.14.2 Lannett Company Oral Codeine Tablet Product Portfolios and Specifications
13.14.3 Lannett Company Oral Codeine Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Lannett Company Main Business Overview
13.14.5 Lannett Company Latest Developments
13.15 Laboratoire Riva
13.15.1 Laboratoire Riva Company Information
13.15.2 Laboratoire Riva Oral Codeine Tablet Product Portfolios and Specifications
13.15.3 Laboratoire Riva Oral Codeine Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Laboratoire Riva Main Business Overview
13.15.5 Laboratoire Riva Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂